Chien-Te Li

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

6-Shogaol, an Active Constituent of Dietary Ginger, Induces Autophagy by Inhibiting the AKT/mTOR Pathway in Human Non-Small Cell Lung Cancer A549 Cells

Jen‐Yu Hung, Ya‐Ling Hsu, Chien-Te Li et al. · Journal of Agricultural and Food Chemistry · 2009 · 157 citations

Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells

Chien-Te Li, Yi‐Min Hsiao, Tzu‐Chin Wu et al. · Journal of Cellular Biochemistry · 2011 · 46 citations

Telomerase Activity, Vorinostat Down-regulated Telomerase, Epigenetics +17

The mechanisms of action of Tianhua^™on antitumor activity in lung cancer cells

Chien-Te Li, Ching‐Hsiung Lin, Te‐Yu Kao et al. · Pharmaceutical Biology · 2010 · 23 citations · Full text